AC
SWTX

Athanor Capital’s SpringWorks Therapeutics SWTX Stock Holding History

Athanor Capital’s Portfolio SWTX Stock Details SWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-17,489
Closed -$1.27M – 1054
2020
Q4 		$1.27M Sell
17,489
-2,901
-14% -$187K 0.05% 261
2020
Q3 		$972K Sell
20,390
-16,181
-44% -$689K 0.04% 242
2020
Q2 		$1.54M Buy
36,571
+22,265
+156% +$792K 0.09% 135
2020
Q1 		$386K Sell
14,306
-16,206
-53% -$528K 0.03% 137
2019
Q4 		$1.17M Buy
+30,512
New +$714K 0.07% 141

Other funds holding SWTX

O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return